After several years of collaboration, a global patient preference study conducted in partnership with the International Federation of Crohn's & Ulcerative Colitis Associations (IFCCA) and KU Leuven (Belgium) has been published, providing new insights into what people living with Inflammatory Bowel Disease (IBD) value most when choosing treatments.

The World IBD Day 2026 Conference Report is now available, capturing the key discussions, insights and recommendations from the International World IBD Day Roundtable and Asia-Pacific Networking Meeting held in Singapore on 16 May 2026.